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OBJECTIVES We sought to evaluate the results of percutaneous coronary intervention (PCI) in elderly
patients in contemporary practice.
BACKGROUND Prior studies of PCI in the elderly population demonstrate increased in-hospital mortality,
but these studies are limited by small population size.
METHODS Using the American College of Cardiology–National Cardiovascular Data Registry (ACC–
NCDR) of 100,253 patients, the in-hospital outcomes in all 8,828 PCI procedures performed
on octogenarians were evaluated. Patients underwent PCI between 1998 and 2000 at over 145
participating centers.
RESULTS The mean age was 83.72  3.02 years, with female preponderance (53%). The PCI was
considered angiographically successful in 93%, stents were placed in 75%, and the post-PCI
length of stay was 3.3 5.1 days. Overall in-hospital mortality was 3.77% but was only 1.35%
in PCI without recent myocardial infarction (MI) within one week (p  0.0001). Patients
having PCI within 6 h of the onset of their MI had an increase in mortality tenfold (13.79%)
compared with patients without a recent MI (p 0.0001). All groups that were defined based
on time of PCI after MI onset up to seven days had increased mortality (all p  0.0001).
Older age (odds ratio [OR] of 1.03 per incremental year), depressed ejection fraction (EF)
(OR 0.69 per 10 points for EF 60%), and time of PCI after MI onset (6 h, OR 6.87; 6
to 24 h, OR 5.66; 24 h to one week, OR 2.93) were most strongly predictive of outcome by
multivariate analysis. The predicted mortality from the multivariate model correlated well
with the observed in-hospital mortality up to 20% mortality. A 254-point nomogram was
constructed employing the logistic model using a weighted point system.
CONCLUSIONS In patients 80 years old, PCI has good success and acceptable mortality. The presence of
an acute or recent MI substantially increases the risk of in-hospital death. (J Am Coll
Cardiol 2002;40:394–402) © 2002 by the American College of Cardiology Foundation
Octogenarians experience increased in-hospital complica-
tions and mortality after percutaneous coronary intervention
(PCI) (1–3). The original National Heart, Lung and Blood
Institute (NHLBI) studies (4–6) and the initial American
Heart Association/American College of Cardiology (AHA/
ACC) guidelines (7,8) noted that the very elderly consti-
tuted a special patient population with worse outcomes.
Specifically, although PCI could be performed with a high
success rate (85% to 90%) in the years 1985 to 1995
(1–3,9–13), the increased mortality (2% to 20%) and more
frequent ischemic events observed (5% to 19%) mandated a
more conservative approach to patient selection. However,
given the 5% to 10% in-hospital mortality of coronary artery
bypass graft (CABG) in this group, PCI has continued to
be an acceptable option in selected patients, especially
those with refractory angina. Recent progress in address-
ing the adverse lesion and patient characteristics com-
monly present in the elderly, such as calcified lesions, low
ejection fraction (EF), prior myocardial infarction (MI),
diffuse disease, and co-morbid conditions, is commonly
believed to have significantly improved PCI outcomes in
this patient group.
The goal of this study was to analyze the current
experience in octogenarians (1998 to 2000) within the
American College of Cardiology–National Cardiovascular
Data Registry (ACC–NCDR) and to better understand the
outcomes in this unique patient group in current practice.
The in-hospital mortality in all 8,828 procedures in octo-
genarians contained in the registry was evaluated, and
indices of severity of disease and co-morbid conditions
predictive of outcome were assessed. Besides examining
which clinical and procedural variables predict in-hospital
mortality in current practice, a logistic model and nomo-
gram were constructed that accurately predict risk.
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METHODS
Data collection. The ACC–NCDR catalogs clinical data
and outcomes in 100,253 PCI procedures, including the
impact of current device use and adjunctive pharmacother-
apy, collected prospectively from 145 institutions across the
U.S. and entered in a common database format. The
development of this national registry is described in a
separate publication (14), as is a risk adjustment mortality
model derived from these data (15).
The data are entered into various ACC-approved com-
mercial or privately developed databases in sites at partici-
pating institutions. The data collected are exported in a
standard format to Heart House (Bethesda, Maryland).
Only institutions with submissions passing the inclusion/
exclusion criteria for data completeness were included. The
first PCI procedure performed in any individual patient
during a qualifying hospitalization was chosen for analysis.
In all, 100,253 patient procedures passed the screening for
inclusion in the registry. This screening process required
that 99% completeness be achieved in all outcome variables
(14,15).
The strengths of this registry include the use of standard-
ized data definitions, data completeness assessment and
procedures, geographic and institutional diversity, and the
large sample size over a relatively short, contemporary time
frame (1998 to 2000). The complete definitions of all
variables were prospectively defined by a committee of the
ACC and are available at the ACC website (http://
www.acc.org/ncdr/cathlab.htm).
Data analysis. The procedures in all 8,828 octogenarians in
the registry were included in the analysis. Octogenarians
were identified by comparing the date of birth field and
procedure date, with inclusion of all patients 80 years of age
and older. Over 70 data elements were selected for analysis,
including patient demographic data (e.g., age, gender), risk
factors (e.g., smoking, diabetes), medical history data (e.g.,
number of vessels diseased, prior MI, EF), PCI indications,
PCI presentations, and angiographic findings as described
previously (14,15). These data were then extracted from the
registry and sent to the data analysis center in flat file
format. The data were then entered into a dataframe in
S-Plus for analysis. Multiple imputation was done in S-plus
according to the method of Harrell (16,17). Data analysis
was performed using both imputed data and non-imputed
data. Multivariate models were derived for both, but the
nomogram uses the imputed data. Fewer than 100 cases had
data imputed in any field.
Continuous data are expressed as mean  SD, and
categorized data as proportions. Continuous data were
compared by analysis of variance and categorized data by chi
square (2). A p value 0.05 was considered significant.
Odds ratios (OR) and 95% confidence methods were
calculated to assess predictive value. For modeling, multiple
imputation was used to restore missing data. Correlates of
binary events were determined by logistic regression with
backward elimination. The discrimination of the model was
assessed by the area under the receiver operating character-
istic curves; the model was validated and calibrated accord-
ing to the method of Harrell (16). A nomogram was then
constructed from the model based on proportional linear
weights.
RESULTS
Demographics. The mean age of the 8,828 octogenarians
was 83.72  3.02 years. There was a preponderance of
women (53%). Indications for performing PCI were: stable
angina, 945 (10.7%); unstable angina, 4,924 (55.8%); acute
MI (within seven days), 2,901 (32.9%); and 58 were not
characterized. In this patient group, 22% had diabetes, 35%
had heart failure, 29% had prior MI, and 21% had prior
CABG. The mean EF was 51  17% in 6,206 patients in
whom ejection was calculated by concurrent contrast left
ventriculography.
In-hospital outcome. The in-hospital mortality was 3.77%
(333/8,828). In 93% of cases, PCI was considered angio-
graphically successful, and the mean length of hospital stay
was 3.33  5.12 days. Stents were placed in 75% of
procedures, and multi-site PCI was performed in 35% of
cases. Other complications included Q-wave MI in 0.52%,
cerebrovascular accidents (CVA) in 0.46%, renal failure in
2.15%, and major vascular complications in 3.73% of cases.
Patients who died had a significantly longer hospital length
of stay post PCI (5.3 7.6 days) than those discharged alive
(3.3  5.0 days, p  0.0001).
INFLUENCE OF OCCURRENCE AND TIMING OF PCI IN RELA-
TION TO RECENT MYOCARDIAL INFARCTION. As illustrated
in Tables 1 and 2, numerous clinical and procedural char-
acteristics were strongly associated with the occurrence and
timing of PCI in patients with acute MI. This association
includes age, several conventional risk factors for coronary
artery disease, prior revascularization procedures, presence
of severe angina, heart failure, and shock. Age was also
significantly associated with recent MI (p  0.001) due to
small differences in the mean age among groups. Diabetes
(p  0.01), hypertension (p  0.001), and prior PCI or
CABG (each p  0.001) were also strongly associated with
this factor. Consequently, because nearly all of the tested
clinical and procedural variables were associated with MI,
Abbreviations and Acronyms
ACC  American College of Cardiology
AHA  American Heart Association
CABG  coronary artery bypass graft surgery
CVA  cerebrovascular accident
EF  ejection fraction
LV  left ventricular
NCDR  National Cardiovascular Data Registry
NHLBI  National Heart, Lung, and Blood Institute
PCI  percutaneous coronary intervention
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multivariate analysis was crucial to the data analysis once the
univariate predictors were identified.
As shown in Table 2, the incidence of most complications
and length of hospital stay were closely associated with MI.
A PCI done within 24 h of the onset of MI predicted the
occurrence of CVA, renal failure, and vascular complica-
tions in addition to death. The incidence of Q-wave MI
could not be shown to relate to the timing of PCI.
As shown in Figure 1, the occurrence and timing of MI
was strongly predictive of mortality. If there was no MI
within seven days of PCI, the mortality was 1.35%, but was
4.93% if an MI had occurred between 24 h and seven days
prior to PCI, 9.87% if onset was within 6 to 24 h, and
13.79% if within the past 6 h (p 0.0001). This latter point
can be emphasized by noting that PCI done within 6 h of
MI onset was associated with a tenfold increase in mortality
compared with elective PCI. The presence of cardiogenic
shock (p  0.0001) and urgent/emergent/salvage indication
(p  0.0001) were strong covariant predictors in this group.
Shock was strongly predictive of outcome. Of the 240
(3%) octogenarians who underwent PCI who fulfilled the
pre-specified shock definition in the ACC–NCDR (see
Appendix), 104 (43%) died, while 136 (57%) were dis-
charged alive. Of the 333 patients in the total group who
died, shock was present in 31%, compared with an incidence
of 2% of the 8,495 patients who survived (p  0.0001).
Urgent, emergent, or salvage indication was present in 45%
of cases and was also highly predictive of outcome (p 
0.0001). Both of these situations were also highly co-linear
with the MI variables, in particular the non-elective proce-
dure indications.
Gender was not predictive of major adverse coronary
events, including in-hospital mortality. Men experienced
3.63% mortality versus 3.94% mortality in women (p 
0.48). Similarly, gender did not predict Q-wave MI (0.53%
vs. 0.49%, p  0.93), CVA (0.33% vs. 0.60%, p  10), or
renal failure (2.36% vs. 1.94%, p  0.19). However, women
did suffer an increased incidence of major vascular compli-
cations (2.58% vs. 4.74%, p  0.0001) and had longer
post-procedure hospital length of stay (3.17  5.25 days vs.
3.48  4.99 days, p  0.003) than men.
Unstable angina was not associated with worse outcomes
compared with the stable angina cohort in the patients
without an acute MI. There was no difference noted in
Table 1. The Relationship of Clinical Variables to PCI in Patients With and Without an Acute MI
Total
(n  8,828)
No MI
(n  5,927)
MI <6 h
(n  863)
MI 6–24 h
(n  679)
MI 1–7 days
(n  1,359) p Value
Age 83.73  3.02 83.58  2.89 83.90  3.17 84.10  3.30 84.07  3.25 0.0001
Women 53% 51% 55% 56% 56% 0.002
Diabetes 22% 22% 18% 21% 24% 0.01
Hypertension 71% 73% 65% 64% 70% 0.0001
History of renal failure 6.5% 6.5% 5.8% 5.8% 7.7% 0.24
Chronic lung disease 13% 13% 12% 12% 13% 0.62
Cerebrovascular disease 16% 16% 14% 14% 17% 0.12
Peripheral vascular disease 17% 17% 14% 14% 16% 0.008
Heart failure 35% 31% 36% 40% 46% 0.0001
Class III–IV angina 66% 70% 51% 59% 60% 0.0001
Previous MI 29% 32% 24% 23% 26% 0.0001
Previous CABG 21% 24% 13% 15% 14% 0.0001
Previous PCI 29% 23% 17% 20% 18% 0.0001
Thrombolysis 5% 0% 13% 15% 14% 0.0001
Acute MI indication 23% 2% 90% 75% 48% 0.0001
Shock as indication 3% 0% 14% 8% 3% 0.0001
Urgent/emergent/salvage 55% 68% 12% 22% 43% 0.0001
Ejection fraction 51  17 53  17 45  15 46  16 48  20 0.0001
(n  6,206) (n  4,192) (n  566) (n  462) (n  986)
CABG  coronary artery bypass graft surgery; MI  myocardial infarction; PCI  percutaneous coronary intervention.
Table 2. The Relationship of Angiographic and Outcome Variables to PCI in Patients With and Without an Acute MI
Total
(n  8,828)
No MI
(n  5,927)
MI <6 h
(n  863)
MI 6–24 h
(n  679)
MI 1–7 days
(n  1,359) p Value
Multisite PCI 35% 35% 28% 36% 34% 0.0006
Stent placement performed 75% 75% 69% 77% 79% 0.0001
Angiographic success 93% 94% 91% 92% 91% 0.0007
Post-PCI LOS 3.33  5.12 2.64  4.79 5.76  6.70 4.85  5.02 4.06  4.67 0.0001
Q-wave MI 0.52% 0.46% 0.93% 0.74% 0.44% 0.26
CVA 0.46% 0.34% 1.05% 0.89% 0.44% 0.01
Renal failure 2.15% 1.45% 3.6% 3.55% 3.61% 0.0001
Vascular complications 3.73% 2.87% 6.72% 6.04% 4.42% 0.0001
CVA  cerebrovascular accident; LOS  length of stay. Other abbreviations as in Table 1.
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death (1.2% vs. 1.8%, p  0.18) or Q-wave MI (0.47% vs.
0.42%, p  0.85). Surprisingly, patients with stable angina
had a longer post-procedure hospital length of stay (3.15 
6.2 vs. 2.52  4.1 days, p  0.0001), despite similar
angiographic success (95% vs. 91%, p  0.13) and stent
utilization (75% vs. 75%, p  0.97).
Ejection fraction as evaluated by concurrent contrast left
ventriculography was calculated in 6,206 patients of the
8,828 total patients (70.3%). This included 4,192/5,927
(70.7%) patients without concurrent MI, 566/863 (65.6%)
patients with MI 6 h, 462/679 (68.0%) patients with MI
6 to 24 h, and 986/1,359 (72.6%) patients with MI one to
seven days. Ejection fraction was 51  17% in the total
patient group but was 41  36% in the 207 patients who
had in-hospital death (62.1% of those who died) versus
51  16% in the remainder (70.6% of those discharged)
who survived. Ejection fraction was also strongly associated
with recent MI; the “no recent MI” group who had left
ventriculograms performed had an EF of 53  17% com-
pared with 45  15% in the MI 6-h group, 46  16% in
the 6- to 24-h group, and 48  20% in the one- to
seven-day group (p  0.0001).
AGE. Despite the fact that all patients in this study were age
80 or greater, age evaluated as a continuous variable was
predictive of in-hospital mortality. Age was 84.38  3.16
years in those who died and 83.70 3.01 in those who were
discharged alive (p  0.0001).
POST-PCI HOSPITAL LENGTH OF STAY. Length of hospital
stay after PCI has been shown to be a surrogate marker of
cost. As shown in Table 2, length of stay was strongly
correlated with recent acute MI (p  0.0001). Patients who
had PCI without MI in the previous seven days had a mean
length of hospital stay of 2.64  4.79 days compared with
5.76  6.70 days in the MI 6-h group, 4.85  5.02 days
in the MI 6- to 24-h group, and 4.06 4.67 in the MI one-
to seven-day group. Additionally, length of stay was
strongly predictive of in-hospital mortality: although the
mean length of stay was 3.33  5.11 days in all 8,828
patients, it was 5.31  7.56 days in those who died versus
3.26  4.98 days in those discharged alive (p  0.0001).
COMPLICATIONS AND MORTALITY. Patients suffering
procedural-related complications such as Q-wave MI,
stroke, acute renal failure, or peripheral vascular complica-
tions had a higher in-hospital mortality (Table 3).
Multivariate analysis. Nine pre-procedure variables were
shown to be multivariate predictors of in-hospital mortality.
The variables associated with increased mortality were
increasing age, recent MI and its timing relative to the PCI
procedure, renal failure, lung disease, peripheral vascular
disease, and EF 60%. Shock and acuteness (elective,
urgent, emergent, or salvage) were excluded from the model
due to co-linearity with acute MI. As can be seen in Table
4, the presence of a recent acute MI was clearly the single
most predictive factor in determining risk of mortality. Also,
the timing of the PCI after MI onset, especially in the first
24 h, was predictive. Prior PCI was found to be associated
with a decreased likelihood of in-hospital mortality. The
OR and 95% confidence interval (CI) for all multivariate
predictors are shown in Table 4. Table 5 displays the data
analysis for unimputed data.
CONSTRUCTION OF THE NOMOGRAM. A nomogram was
constructed using the correlation coefficients in Table 4 as
weights. The point value was derived from the statistical
Figure 1. Mortality in all octogenarians, those without a prior acute
myocardial infarction and those with a prior acute myocardial infarction
(MI) within 6 h, 6 to 24 h and between one and seven days from the onset
of the infarction to percutaneous coronary intervention.
Table 3. The Relationship of PCI-Related Complications to
In-Hospital Mortality
Mortality
Without
Complication
Mortality
With
Complication OR p Value
Q-wave MI 3.72% 17.39% 5.45 0.0001
Stroke 3.71% 16.67% 5.19 0.0001
Acute renal failure 3.23% 28.85% 12.21 0.0001
Vascular complication 3.62% 8.16% 0.0001 0.0001
OR  odds ratio. Other abbreviations as in Table 1.
Table 4. Multivariate Correlates of In-Hospital Mortality
OR 95% CI p Value
Age (per year) 1.03 1.00–1.07 0.0680
Acute MI 6 h 6.87 5.02–9.40 0.0001
Acute MI 6–24 h 5.66 3.97–8.07 0.0001
Acute MI 1–7 days 2.93 2.09–4.11 0.0001
Renal failure 1.87 1.32–2.66 0.0005
Chronic obstructive pulmonary
disease
1.27 0.93–1.73 0.1307
Peripheral vascular disease 1.44 1.08–1.94 0.0146
Ejection fraction (for every 10-
point decrement, below 60%)
0.69 0.65–0.73 0.0000
Prior PCI 0.62 0.46–0.84 0.0022
ROC  0.829, corrected ROC  0.823. Abbreviations as in Table 1.
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analysis for each predictive variable. The ability to predict
mortality accurately depends on the model’s being calibrated
to function well over a range of probabilities of mortality.
Figure 2 is a graphical display of actual versus predicted
probability of mortality in this patient group, based on the
logistic model. Figure 2 illustrates that the calibration of the
model is very strongly and accurately predictive up to a 20%
mortality, with a mean absolute error of 0.003, demonstrat-
ing that it is an excellent model up to that level of risk. For
the smaller number of patients with very high mortality risk,
the model is no longer accurate in assessing precise risk
(other than to predict that it is very high and20%). Figure
3 shows a similar graphic for unimputed data.
The nomogram incorporated seven variables (including
the three based on timing of PCI relative to MI onset as one
variable) using a point score system of 0 to 254 points. Table
6 displays the point value assigned to each predictive value.
Table 7 shows the correlation of total points to prediction of
in-hospital mortality.
Specific patient examples using the nomogram are enu-
merated below:
1. An 84-year-old man admitted without an acute MI and
an EF of 61% with no prior cardiac or medical illnesses
and a 90% left anterior descending coronary stenosis: 56
points, 1% likelihood of death.
2. An 88-year-old man one week after an anterior wall MI
treated with thrombolysis, EF of 20%: 6  79  36 
121 points, 6% likelihood of death.
3. An 82-year-old woman with ST elevation in the inferior
leads and chest pain 6 h duration, EF of 30%, with
creatinine 2.5 and known peripheral vascular disease:
Table 5. Unimputed Multivariate Model
Variable OR 95% CI p Value
Age 1.05 1.01–1.11 0.017
Acute MI 6 h 7.87 5.31–11.62 0.0001
Acute MI 6–24 h 5.46 3.51–8.48 0.0001
Acute MI 1–7 days 2.91 1.90–4.54 0.0001
Renal failure 2.94 1.90–4.54 0.0001
COPD 1.13 0.75–1.70 0.5467
PVD 1.38 0.95–1.99 0.0887
EF 0.74 0.67–0.81 0.0001
Prior PCI 0.74 0.51–1.09 0.1272
COPD  chronic obstructive pulmonary disease; EF  ejection fraction; PVD 
peripheral vascular disease; ROC  0.801, corrected ROC  0.793. Other abbrevi-
ations as in Table 1.
Figure 2. Correlation of the predicted probability of death from the logistic model with the observed probability of death.
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2  100  27  15  9  153 points, 20% likelihood
of death.
DISCUSSION
The decision to proceed with a percutaneous revasculariza-
tion procedure in octogenarians is influenced by numerous
factors. Important non-cardiac considerations to consider
include baseline mental status, nutritional status, and coex-
isting renal, cerebral, pulmonary, and vascular diseases.
Additionally, elderly patients are more often women, are
more likely to present with acute coronary syndromes, and
frequently have adverse coronary morphologic features, all
of which predispose to more acute complications of inter-
vention. Nevertheless, percutaneous revascularization can
usually be performed with acceptable results. Additionally,
the elderly are at increased risk of death after acute vessel
closure, and there is an increased rate of vascular complica-
tions (1–13,18). The interventionist must closely monitor
volume status, contrast load, urine output, bleeding, and
vascular integrity during and immediately after the proce-
dure to minimize adverse events in this often brittle patient
population.
Current study. This report from the ACC–NCDR Reg-
istry analyzes data from the largest published series of
contemporary octogenarians undergoing coronary interven-
tion. Because the cases were performed in the years from
1998 to 2000, the results reflect current practice, including
case selection, device use, antiplatelet therapies, and com-
plication rates. The 8,828 procedures analyzed represent
8.8% of all cases in the registry and are confirmed to be
consecutively collected.
The results of this study not only quantitate the effect of
several variables long associated with mortality and adverse
outcomes in this patient population but also identify some
new features to consider. The most important clinical
predictors of in-hospital mortality were the presence of an
acute MI and the time after onset of the infarction.
Numerous clinical characteristics known to be univariate
predictors of mortality were strongly associated with timing
of PCI after acute MI onset, a feature not previously
emphasized.
Implications for practice. The optimal treatment of acute
MI in the elderly remains an unsettled issue, and the data in
this registry reveal important new information. Performing
Figure 3. Correlation between predicted probability of mortality and actual mortality risk—unimputed data model.
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PCI in elderly patients has been shown to be effective in
opening the infarct-related vessel and reducing in-hospital
mortality without the hemorrhagic complications associated
with thrombolysis (18–23). The current study suggests that
PCI is highly effective in this population as measured by
angiographic success, but worse clinical outcomes than
expected in elective procedures can be anticipated. Several
population-based observational studies comparing the out-
comes of thrombolysis and primary PCI in elderly patients
with acute MI have had mixed results (24–26). In the
SHOCK trial (27), patients over age 75 who underwent
emergent revascularization with cardiogenic shock had a
41% higher mortality than patients who received aggressive
medical therapy including intra-aortic balloon pump. Small
observational studies in the shock subgroup also consistently
demonstrate that PCI in elderly patients in shock has a high
in-hospital mortality (28), a finding demonstrated in detail
in the current study.
Of note is the finding that elderly patients with unstable
angina are not at increased risk for post-PCI in-hospital
mortality, supporting the contemporary practice of consid-
ering this indication one of the most compelling for revas-
cularization in elderly patients (12,18–20). Additionally, the
efficacy of PCI in elderly patients with multivessel disease
undergoing elective procedures as an alternative top bypass
surgery demonstrates also that its employment in carefully
selected patients has merit.
Study limitations. The limitations of this study are those
of any multi-center registry. As previously described
(11,12), the ACC–NCDR database fields were developed
with input from over 50 physicians over a three-year period.
Every variable definition was considered in depth before
data collection began and collected in a data dictionary
present at all sites for reference. Nevertheless, it is impos-
sible to presume that every center and every operator
interpreted clinical and angiographic variables in the same
way. Similarly, there is no way to determine inter-observer
and inter-center differences in denoting any particular vari-
able. However, these definitions are a standard used in
interventional practice and were originally designed to be
intuitively applied by the clinician.
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APPENDIX
1. Renal Failure
Indicate whether the patient has any documented
history of renal (kidney) failure diagnosed and treated
with medication, low protein diet, or dialysis by a
physician. It is diagnostic if a baseline creatinine
2.0 mg/dl is significant.
2. Chronic Lung Disease
Indicate whether the patient has a documented history
of chronic lung disease. The patient should be on
pharmacologic therapy (inhalers, theophylline, mino-
phylline, or steroids) and/or have a forced expiratory
volume at 1 s 75%, room air oxygen pressure 60% or
room air carbon dioxide pressure 50.
3. Cardiogenic Shock
Indicate whether the patient experienced cardiogenic
shock at the time of the procedure. Cardiogenic shock is
a clinical state of hyperfusion characterized by systolic
pressure 80 mm Hg and central filling pressure
20 mm Hg, or a cardiac index 1.8 l/min/m2. Shock
is also considered present if intravenous inotropes and/or
intra-aortic balloon pump are needed to maintain a
systolic blood pressure 80 mm Hg and a cardiac index
of 1.8 l/min/m2.
4. Emergent/Urgent/Salvage Indication
Urgency
Indicate the status of the current procedure:
Elective: The procedure could be deferred without
increased risk of compromised cardiac outcome.
Urgent: Not elective and not emergent. The procedure
is required during the same hospitalization in order to
minimize chance of further clinical deterioration. Wors-
ening sudden chest pain, congestive heart failure (CHF),
acute myocardial infarction (MI), anatomy, intra-aortic
balloon pump, unstable angina with intravenous nitro-
glycerin, or rest angina may be included.
Emergent: Ongoing ischemia including rest angina
despite maximal therapy (medical or intra-aortic balloon
pump) or acute evolving MI within 24 h prior to surgery.
Pulmonary edema requiring intubation. Also, hemody-
namic instability, which includes shock with or without
circulatory support.
Salvage: The procedure is required due to cardiac
arrest with cardiopulmonary resuscitation immediately
prior to entering the operating room or catheterization
laboratory.
5. Number of Lesions Successfully Dilated
Indicate the number of lesions where the residual
post-intervention stenosis is 50% of the arterial lumi-
nal diameter, Thrombolysis In Myocardial Infarction
flow grade is 3 and the minimal decrease in stenosis is
20%.
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6. Vascular Complications
Vascular complications include:
● Pseudoaneurysm. The occurrence of an aneurysmal dila-
tion of the artery at the site of catheter entry demon-
strated by arteriography or ultrasound.
● Bleeding. Blood loss at the site of arterial or venous access
or due to perforation of a traversed artery or vein
requiring transfusion and/or prolonging the hospital stay,
and/or causing a drop in hemoglobin-E 3.0 g/dl. Bleed-
ing attributable to the vascular site could be retroperito-
neal, a local hematoma E 10 cm diameter, or external.
● Occlusion. Total obstruction of the artery usually at the
site of access requiring surgical repair.
● Loss of distal pulse requiring therapy.
● AV fistula. A connection between the femoral artery and
femoral vein that is demonstrated by arteriography or
ultrasound.
● Dissection.
7. Congestive Heart Failure
Physical should have CHF documented in the record
or there should be a history of fluid retention during that
same period, although this is not an absolute require-
ment. Patient should have received diuretics or cardiac
medication to treat the failure. There should be a history
of one or more of the following: paroxysmal nocturnal
dyspnea, dyspnea on exertion due to heart failure, pul-
monary congestion on x-ray, or ventricular S3 gallop.
Bilateral pedal edema or dyspnea alone is not diagnostic.
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